BIOMAT Database Logo BIOMAT Database Logo

Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. 2002

K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
Dept. of First Surgery, Gunma University School of Medicine, Ueda Kidney Clinic, Maebashi, Japan. katukada@topaz.ocn.ne.jp

BACKGROUND Triple therapy is accepted as the treatment of choice for Helicobacter pylori eradication, but there is no consensus on how long the therapy should be maintained in haemodialysis (HD(+)) patients. Our aims in this study were to evaluate the safety and efficacy of the 7-day triple therapy in HD(+) patients. METHODS Forty-seven HD(+) and 55 HD(-) patients with dyspepsia underwent endoscopy. The prevalence of H. pylori was detected by Giemsa stain, followed by the urea breath test (UBT). H. pylori(+) patients were scheduled to undergo 7-day triple therapy and the success of eradication was investigated by UBT. RESULTS Forty-five (44%) patients were positive for H. pylori. Forty of them underwent triple therapy and 39 (98%) patients completed the treatment. Eradication was successful in 32 (82%) and unsuccessful in 7 (18%) patients. There was no significant difference between these groups in age, gender, endoscopic findings or HD, and only previous treatment was significant for eradication failure by univariate and multivariate logistic regression analysis. Side effects were observed in 2 (15%) of 13 HD(+) and 3 (11%) of 27 HD(-) patients, and one HD(-) patient had to stop medication because of severe nausea and vomiting. The eradication rate was 93% (28/30) in patients without previous treatment. The triple therapy was unsuccessful in 7 patients, and 4 of them again underwent 7-day triple therapy, but all resulted in failure. CONCLUSIONS Seven-day triple therapy is safe and effective for primary treatment of H. pylori infection in both HD(+) and HD(-) patients, but a new treatment is necessary for patients with previous treatment.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D005773 Gastroscopy Endoscopic examination, therapy or surgery of the interior of the stomach. Gastroscopic Surgical Procedures,Surgical Procedures, Gastroscopic,Gastroscopic Surgery,Surgery, Gastroscopic,Gastroscopic Surgeries,Gastroscopic Surgical Procedure,Gastroscopies,Procedure, Gastroscopic Surgical,Procedures, Gastroscopic Surgical,Surgeries, Gastroscopic,Surgical Procedure, Gastroscopic

Related Publications

K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
August 1996, Alimentary pharmacology & therapeutics,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection].
February 1998, Gastroenterologia y hepatologia,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
April 1996, Alimentary pharmacology & therapeutics,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection.
August 1994, Alimentary pharmacology & therapeutics,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
December 2003, Journal of the Formosan Medical Association = Taiwan yi zhi,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori.
June 1996, Alimentary pharmacology & therapeutics,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
September 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
December 1996, Zhonghua nei ke za zhi,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
April 1998, Alimentary pharmacology & therapeutics,
K Tsukada, and T Miyazaki, and H Katoh, and N Masuda, and H Ojima, and Y Fukai, and M Nakajima, and R Manda, and M Fukuchi, and H Kuwano, and O Tsukada
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.
June 1996, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!